<DOC>
	<DOCNO>NCT00584532</DOCNO>
	<brief_summary>Genistein Combined Polysaccharide ( GCP ) may play role secondary chemopreventive agent treatment localized prostate cancer .</brief_summary>
	<brief_title>Effects Genistein Concentrated Polysaccharide ( GCP ) Prostate Cancer Active Surveillance .</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Participants must male pathological diagnosis prostate cancer Pathological diagnosis prostate cancer must confirm file CRA prior study entry . No treatment ( surgery , radiation , hormone ) prior study entry . PSA 2.0 10.0 ng/ml . If PSA &gt; 10.0 , patient must Active Surveillance 12 month prior study initiation . No known allergy soy soy product . The patient currently take 2 gram genistein day nutritional diet enhance supplement ( OTC supplement ) . Participant previous GCP clinical trial . Normal Chemistry value prior study entry . No pathological documentation prostate cancer . Prior treatment prostate cancer . PSA &gt; 10.0 ng/ml Active Surveillance 12 month . Allergy soy soy product . Abnormal chemistry value .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Localized</keyword>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
</DOC>